Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan
Clinical Drug Investigation · 2024
DOI: 10.1007/s40261-023-01337-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Yukiko Ishibashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Saga University Hospital, 5-1-1, Nabeshima, Saga, 849-8501, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Drug-Related Side Effects and Adverse Reactions, Delirium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: KAKENHI.
Themen: Delir
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Several associations between diabetes mellitus and delirium have been reported; however, they have been inconsistent, and evidence on the effects of antidiabetic medications on delirium is also limited. This study aimed to investigate whether the use of antidiabetic drugs is a risk factor for delirium development. METHODS: Using the Japanese Adverse Event Reporting Database, we analyzed 662,899 reports between 2004 and 2022. Reporting odds ratios (RORs) and 95% confidence intervals (CIs) for delirium associated with diabetes and using each antidiabetic medication were calculated after adjusting for potential confounders. RESULTS: Overall, 8892 of the reports analyzed were associated with delirium. A comparison of the incidence of delirium between patients with and without diabetes showed no significant difference, with 1.34% in patients without diabetes and 1.37% in those with diabetes. In each antidiabetic medication, signals for delirium were detected for sulfonylurea (crude ROR, 1.35; 95% CI 1.21-1.51) and insulin (crude ROR, 1.28; 95% CI 1.13-1.44). These results were maintained even after adjusting for factors with potential confounders (sulfonylurea: adjusted ROR, 1.75; 95% CI 1.54-2.00, insulin: adjusted ROR, 1.35; 95% CI 1.20-1.54). CONCLUSIONS: Our results suggest no association between diabetes and delirium; however, using sulfonylurea and insulin may be associated with delirium development. Nonetheless, these findings should be validated in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Saga University Hospital, 5-1-1, Nabeshima, Saga, 849-8501, Japan.
- Department of Pharmacy, Saga University Hospital, 5-1-1, Nabeshima, Saga, 849-8501, Japan. sogawari@cc.saga-u.ac.jp.
- Department of Emergency and Critical Care Medicine, Saga University Hospital, Saga, Japan.
- Faculty of Medicine, Institute of Nursing, Saga University, Saga, Japan.
- Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
- Wakahisa Hospital, Fukuoka, Japan.
Förderung
- KAKENHI
Zitieren
APA
Ishibashi, Y., Sogawa, R., Ogata, K., Matsuoka, A., Yamada, H., Murakawa-Hirachi, T., Mizoguchi, Y., Monji, A., & Shimanoe, C. (2024). Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan. Clinical Drug Investigation. https://doi.org/10.1007/s40261-023-01337-9
Vancouver
Ishibashi Y, Sogawa R, Ogata K, Matsuoka A, Yamada H, Murakawa-Hirachi T, et al. Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan. Clinical Drug Investigation. 2024. doi:10.1007/s40261-023-01337-9
BibTeX
@article{Ishibashi2024,
author = {Ishibashi, Yukiko and Sogawa, Rintaro and Ogata, Kenji and Matsuoka, Ayaka and Yamada, Haruna and Murakawa-Hirachi, Toru and Mizoguchi, Yoshito and Monji, Akira and Shimanoe, Chisato},
title = {Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan},
journal = {Clinical Drug Investigation},
year = {2024},
doi = {10.1007/s40261-023-01337-9}
}
EUVIMED